Moderna’s Stock Crumbled This Week. Investors Are Questioning Its Spectacular Surge.
Stock in the Covid-19 vaccine maker Moderna fell 16% Wednesday as investors seemed to struggle to value shares that have nearly tripled in value this year.Moderna
(ticker: MRNA) shares had an unbelievable run from the beginning of the year through the…
